Lannett Company, Inc. (NYSE:LCI)

CAPS Rating: 2 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Recs

1
Player Avatar FinancialModeler (27.14) Submitted: 3/11/2009 4:08:43 PM : Underperform Start Price: $5.30 LCI Score: -485.93

Whoever said this stock is under valued needs to learn what value really is. LCI has a PE ratio over 100. The stock trades within 10% of its 52 week high. Returns on assets, equity, and capital is almost nothing. No dividend. Less than 2% profit margin is weak. This is not value.

I want to see this stock drop down to $3 per share before I close this out.

Member Avatar DrGoldin (99.72) Submitted: 11/22/2013 2:09:32 AM
Recs: 0

PEG < 1?

Featured Broker Partners


Advertisement